Skip to search formSkip to main contentSkip to account menu

Triton WR-1339

Known as: WR-1339, triton WR 1339 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Although Triton WR 1339 has been used to block triglyceride or cholesterol removal from plasma, no data are available on the… 
Highly Cited
1979
Highly Cited
1979
Changes in whole plasma and lipoprotien apoprotein concentrations were determined after a single injection of Triton WR 1339 into… 
Highly Cited
1978
Highly Cited
1978
RATS TREATED WITH ETHYNYLOESTRADIOL HAVE MARKED HYPOLIPIDAEMIA: serum cholesterol is decreased to 5%, triacylglycerol to 10% and… 
Highly Cited
1976
Highly Cited
1976
1. Lipoprotein lipase activity was measured in heart homogenates and in heparin-releasable and non-releasable fractions of… 
1958
1958
The administration of triton WR-1339 (300 mg./kg. subcutaneously) to tuberculin-sensitive guinea pigs 2 hours before the… 
Highly Cited
1957
Highly Cited
1957
Sequential changes in the plasma lipids of rats injected with Triton were studied. It was observed that following a dose of… 
Highly Cited
1952
Highly Cited
1952
Injection of triton WR-1339 into rats leads to a rapid increase in the cholesterol, cholate, and various lipid fractions of their…